Cubist Systematic Strategies’s Health Catalyst HCAT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-164,250
| Closed | -$744K | – | 1869 |
|
2025
Q1 | $744K | Buy |
164,250
+26,580
| +19% | +$120K | ﹤0.01% | 947 |
|
2024
Q4 | $973K | Buy |
137,670
+35,584
| +35% | +$252K | 0.01% | 818 |
|
2024
Q3 | $831K | Sell |
102,086
-18,277
| -15% | -$149K | 0.01% | 863 |
|
2024
Q2 | $769K | Sell |
120,363
-125,566
| -51% | -$802K | 0.01% | 830 |
|
2024
Q1 | $1.85M | Buy |
245,929
+243,841
| +11,678% | +$1.84M | 0.01% | 903 |
|
2023
Q4 | $19.3K | Sell |
2,088
-34,075
| -94% | -$316K | ﹤0.01% | 1938 |
|
2023
Q3 | $366K | Buy |
36,163
+26,321
| +267% | +$266K | ﹤0.01% | 1360 |
|
2023
Q2 | $123K | Sell |
9,842
-115,617
| -92% | -$1.45M | ﹤0.01% | 1781 |
|
2023
Q1 | $1.46M | Sell |
125,459
-228,794
| -65% | -$2.67M | 0.01% | 1277 |
|
2022
Q4 | $3.77M | Sell |
354,253
-16,616
| -4% | -$177K | 0.02% | 878 |
|
2022
Q3 | $3.6M | Buy |
370,869
+155,978
| +73% | +$1.51M | 0.02% | 1095 |
|
2022
Q2 | $3.11M | Buy |
214,891
+151,865
| +241% | +$2.2M | 0.02% | 1190 |
|
2022
Q1 | $1.65M | Buy |
63,026
+29,907
| +90% | +$782K | 0.01% | 1639 |
|
2021
Q4 | $1.31M | Buy |
33,119
+2,675
| +9% | +$106K | 0.01% | 1706 |
|
2021
Q3 | $1.52M | Sell |
30,444
-39,271
| -56% | -$1.96M | 0.02% | 1222 |
|
2021
Q2 | $3.87M | Buy |
69,715
+11,863
| +21% | +$659K | 0.04% | 690 |
|
2021
Q1 | $2.71M | Buy |
57,852
+2,716
| +5% | +$127K | 0.03% | 831 |
|
2020
Q4 | $2.4M | Buy |
55,136
+42,566
| +339% | +$1.85M | 0.03% | 837 |
|
2020
Q3 | $460K | Sell |
12,570
-29,503
| -70% | -$1.08M | 0.01% | 1800 |
|
2020
Q2 | $1.23M | Buy |
42,073
+40,508
| +2,588% | +$1.18M | 0.02% | 1067 |
|
2020
Q1 | $41K | Buy |
+1,565
| New | +$41K | ﹤0.01% | 2025 |
|